Epstein–Barr virus (EBV) is a human herpesvirus associated with a number of malignancies. EBV establishes a latent infection in human B cells in vitro, and infected lymphoblastoid cells proliferate indefinitely as a result of virus activation of cellular signalling pathways. Latently infected cells express a viral oncoprotein called the latent membrane protein-1 (LMP-1). LMP-1 signals both proliferative and survival signals to the infected B cell. The switch from latency to lytic replication is associated with upregulation of an N-terminally truncated LMP-1, called lytic LMP-1 (lyLMP-1). To understand better the relationship between LMP-1 protein function and the virus life cycle, LMP-1 and lyLMP-1 were precisely localized in infected B cells. Immunoelectron microscopy of latently infected cells revealed LMP-1 localized in discrete patches in the plasma membrane. Unexpectedly, immunogold-labelled LMP-1 was found in vesicles budding from the plasma membrane into the extracellular space and in small membrane vesicles accumulating in conditioned medium from infected cells. LyLMP-1 immunolabelling was observed only in B95-8 cells harbouring detectable intracellular virus particles and was abundant in the nuclear membrane early, and in the plasma membrane late, following lytic cycle induction. LyLMP-1 immunoreactivity was also observed at sites of virus budding and associated with intracellular virions, suggesting that lyLMP-1 might be incorporated into cytoplasmic virions when budding through the nuclear membrane.
AdlerB.,
SchaadtE.,
KempkesB.,
Zimber-StroblU.,
BaierB.,
BornkammG. W.2002; Control of Epstein–Barr virus reactivation by activated CD40 and viral latent membrane protein 1. Proc Natl Acad Sci U S A 99:437–442
BaichwalV. R.,
SugdenB.1987; Posttranslational processing of an Epstein–Barr virus-encoded membrane protein expressed in cells transformed by Epstein–Barr virus. J Virol 61:866–875
BaichwalV. R.,
SugdenB.1989; The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein–Barr virus are required for transformation. Oncogene 4:67–74
CoffinW. F.III,
EricksonK. D.,
Hoedt-MillerM.,
MartinJ. M.2001; The cytoplasmic amino-terminus of the latent membrane protein-1 of Epstein–Barr virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain. Oncogene 20:5313–5330
DukersD. F.,
MeijP.,
VervoortM. B. H. J.,
VosW.,
ScheperR. J.,
MeijerC. J. L. M.,
BloemenaE.,
MiddeldorpJ. M.2000; Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J Immunol 165:663–670
EricksonK. D.,
MartinJ. M.1997; Early detection of the lytic LMP-1 protein in EBV-infected B-cells suggests its presence in the virion. Virology 234:1–13
EscolaJ.,
KleijmeerM. J.,
StoorvogelW.,
GriffithJ. M.,
YoshieO.,
GeuzeH. J.1998; Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem 273:20121–20127
FennewaldS.,
van SantenV.,
KieffE.1984; Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J Virol 51:411–419
FloettmannJ. E.,
WardK.,
RickinsonA. B.,
RoweM.1996; Cytostatic effect of Epstein–Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Virology 223:29–40
GiddingsT. H.Jr,
O'TooleE. T.,
MorphewM.,
MastronardeD. N.,
McIntoshJ. R.,
WineyM.2001; Using rapid freeze and freeze-substitution for the preparation of yeast cells for electron microscopy and three-dimensional analysis. Methods Cell Biol 67:27–42
HammerschmidtW.,
SugdenB.,
BaichwalV. R.1989; The transforming domain alone of the latent membrane protein of Epstein–Barr virus is toxic to cells when expressed at high levels. J Virol 63:2469–2475
HenleG.,
HenleW.,
DiehlV.1968; Relation of Burkitt's tumor associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci U S A 59:94–101
HiguchiM.,
IzumiK. M.,
KieffE.2001; Epstein–Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proc Natl Acad Sci U S A 98:4675–4680
HoM.,
JaffeR.,
MillerG.7 other authors1988; The frequency of Epstein–Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 45:719–727
HudsonG. S.,
FarrellP. J.,
BarrellB. G.1985; Two related but differentially expressed potential membrane proteins encoded by the Eco RI Dhet region of Epstein–Barr virus B95-8. J Virol 53:528–535
HuenD. S.,
HendersonS. A.,
Croom-CarterD.,
RoweM.1995; The Epstein–Barr virus latent membrane protein-1 (LMP1) mediates activation of NF κ B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10:549–560
IzumiK. M.,
KayeK. M.,
KieffE. D.1997; The Epstein–Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc Natl Acad Sci U S A 94:1447–1452
KavathasP.,
BachF. H.,
DeMarsR.1980; Gamma ray-induced loss of expression of HLA and glyoxylase I alleles in lymphoblastoid cells. Proc Natl Acad Sci U S A 77:4251–4255
KayeK. M.,
IzumiK. M.,
KieffE.1993; Epstein–Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci U S A 90:9150–9154
KaykasA.,
WorringerK.,
SugdenB.2001; CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex. EMBO J 20:2641–2654
KilgerE.,
KieserA.,
BaumannM.,
HammerschmidtW.1998; Epstein–Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J 17:1700–1709
MillerG.,
ShopeT.,
LiscoH.,
StittD.,
LipmanM.1972; Epstein–Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc Natl Acad Sci U S A 69:383–387
MitchellT.,
SugdenB.1995; Stimulation of NF κ B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein–Barr virus. J Virol 69:2968–2976
RaposoG.,
NijmanH. W.,
StoorvogelW.,
LeijendekkerR.,
HardingC. V.,
MeliefC. J. M.,
GeuzeH. J.1996; B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183:1161–1172
StevenA.,
SpearP. G.1997; Herpesvirus capsid assembly and envelopment. In Structural Biology of Viruses pp 312–351 Edited by
ChiuW.,
BurnettW.,
GarceaR. L.
New York: Oxford University Press;
TorrisiM. R.,
CironeM.,
PavanA.,
ZompettaC.,
BarileG.,
FratiL.,
FaggioniA.1989; Localization of Epstein–Barr virus envelope glycoproteins on the inner nuclear membrane of virus-producing cells. J Virol 63:828–832
WangD.,
LiebowitzD.,
KieffE.1988a; The truncated form of the Epstein–Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts. J Virol 62:2337–2346
WildP.,
SchranerE. M.,
CantieniD.,
LoepfeE.,
WaltherP.,
MullerM.,
EngelsM.2002; The significance of the Golgi complex in envelopment of bovine herpesvirus 1 (BHV-1) as revealed by cryobased electron microscopy. Micron 33:327–337
Zimber-StroblU.,
KempkesB.,
MarschallG.,
ZeidlerR.,
Van KootenC.,
BanchereauJ.,
BornkammG. W.,
HammerschmidtW.1996; Epstein–Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival. EMBO J 15:7070–7078